Pelthos Financial Statements From 2010 to 2025

PTHS Stock   26.50  0.48  1.78%   
Pelthos Therapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Pelthos Therapeutics' valuation are provided below:
There are over thirty-seven available trending fundamental ratios for Pelthos Therapeutics, which can be analyzed over time and compared to other ratios. All traders should check out Pelthos Therapeutics' recent fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction.
Check Pelthos Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pelthos Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 825.7 K, Total Revenue of 0.0 or Gross Profit of 159.9 K, as well as many indicators such as Price To Sales Ratio of 27.23, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Pelthos financial statements analysis is a perfect complement when working with Pelthos Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with Pelthos Stock
Check out the analysis of Pelthos Therapeutics Correlation against competitors.
For more information on how to buy Pelthos Stock please use our How to Invest in Pelthos Therapeutics guide.

Pelthos Therapeutics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding636.8 K587.6 K581.2 K
Slightly volatile
Total Current Liabilities4.7 M4.1 M3.1 M
Slightly volatile
Accounts Payable2.4 M1.9 M2.7 M
Pretty Stable
Total LiabilitiesM4.1 MM
Slightly volatile
Short and Long Term Debt Total1.5 M2.2 M746.6 K
Slightly volatile
Other Current Liabilities483.2 K749 K302.4 K
Slightly volatile
Net Debt1.2 M1.7 M648.5 K
Slightly volatile
Cash And Short Term Investments539.1 K513.4 K116.6 K
Slightly volatile
Liabilities And Stockholders Equity1.4 M1.4 M226.2 K
Slightly volatile
Other Stockholder Equity10.4 M18.8 M4.2 M
Slightly volatile
Short and Long Term Debt1.5 M2.2 M746.6 K
Slightly volatile
Short Term Debt1.5 M2.2 M746.6 K
Slightly volatile
Common Stock409613178
Slightly volatile
Net Receivables32.3 K36.4 K39.6 K
Slightly volatile
Other Current Assets652.2 K733.8 K800 K
Slightly volatile

Pelthos Therapeutics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense825.7 K786.4 K143.1 K
Slightly volatile
Gross Profit159.9 K179.9 K196.2 K
Slightly volatile
Other Operating Expenses4.2 M7.6 M2.4 M
Slightly volatile
Research Development989.6 K1.2 M429.6 K
Slightly volatile
Total Operating Expenses4.2 M7.6 M2.4 M
Slightly volatile
Selling General Administrative3.6 M6.4 M1.5 M
Slightly volatile

Pelthos Therapeutics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Cash From Financing Activities6.5 M6.2 M2.2 M
Slightly volatile
Other Cashflows From Financing Activities977.8 K1.1 M1.2 M
Slightly volatile
Other Non Cash Items312.5 K328.9 K317.7 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio27.2330.6433.4015
Slightly volatile
Average PayablesM3.4 M3.7 M
Slightly volatile
ROIC15.0614.34032.5153
Slightly volatile
Research And Ddevelopement To Revenue0.550.620.6796
Slightly volatile
Cash Per Share0.920.87380.2001
Slightly volatile
Income Quality0.40.72810.5967
Slightly volatile
ROE3.082.93120.9862
Slightly volatile
Current Ratio0.350.33530.0556
Slightly volatile
Revenue Per Share0.280.310.3402
Slightly volatile
Interest Debt Per Share5.315.05851.8009
Slightly volatile
Debt To Assets1.521.59678.9903
Slightly volatile
Ebt Per Ebit0.71.05070.6227
Slightly volatile
Return On Capital Employed2.932.78970.9322
Slightly volatile
Quick Ratio0.350.33530.0556
Slightly volatile
Cash Ratio0.130.12570.0288
Slightly volatile
Debt Ratio1.521.59678.9903
Slightly volatile
Price Sales Ratio27.2330.6433.4015
Slightly volatile
Return On Equity3.082.93120.9862
Slightly volatile

Pelthos Therapeutics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap5.4 M6.1 M6.7 M
Slightly volatile
Enterprise Value6.1 M7.2 M7.3 M
Pretty Stable

Pelthos Fundamental Market Drivers

About Pelthos Therapeutics Financial Statements

Pelthos Therapeutics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Pelthos Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Pelthos Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Pelthos Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Research And Ddevelopement To Revenue 0.62  0.55 
Revenue Per Share 0.31  0.28 
Ebit Per Revenue(6.09)(6.40)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Pelthos Stock Analysis

When running Pelthos Therapeutics' price analysis, check to measure Pelthos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pelthos Therapeutics is operating at the current time. Most of Pelthos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pelthos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pelthos Therapeutics' price. Additionally, you may evaluate how the addition of Pelthos Therapeutics to your portfolios can decrease your overall portfolio volatility.